SCHEMBL6000320

SCHEMBL6000320

CCC(C)c1ccc(CCN)c(Oc2ccc(Cl)c(C)c2C)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ADRA1A P35348 1/20 0.34
KDM4E B2RXH2 1/20 0.33
SOS1 Q07889 1/20 0.32
GLA P06280 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTR6 P50406 1/20 0.31
CYP1A2 P05177 1/20 0.31
KCNH2 Q12809 1/20 0.30
HTR1D P28221 1/20 0.30
NPBWR1 P48145 1/20 0.30
MCHR1 Q99705 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000440 0.90 HTR1D (0.39) TAAR1ADRA1AKDM4ECYP1A2HTR1D
SCHEMBL5498668 0.87 TAAR1 (0.36) TAAR1ADRA1ACYP1A2
SCHEMBL5503316 0.86 TAAR1 (0.35) TAAR1ADRA1ACYP1A2
SCHEMBL6000315 0.83 SLC6A4 (0.45) KCNH2
SCHEMBL5502216 0.82 SLC6A4 (0.42) TAAR1ADRA1AKCNH2
SCHEMBL5999811 0.81 PNMT (0.35) TAAR1ADRA1AKDM4EGLASMN1; SMN2
SCHEMBL5497523 0.80 HTR2A (0.43) TAAR1ALDH1A1ADRA1ACYP1A2KCNH2
SCHEMBL5506301 0.78 TAAR1 (0.36) TAAR1ADRA1ACYP1A2
SCHEMBL5497370 0.78 SOS1 (0.41) TAAR1ALDH1A1SOS1SMN1; SMN2HTR6
SCHEMBL5502917 0.77 TAAR1 (0.45) TAAR1ADRA1ASOS1CYP1A2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060058361-A1 Therapeutic diphenyl ether ligands PFIZER INC 2006-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058361-A1 Therapeutic diphenyl ether ligands HTR2B, HTR2C, HTR3B TAAR1 283/4885USP2 2372/4885ALDH1A1 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.